Clinical trial
Antimullerian Hormone as an Indicator fo Ovarian Response in Women Receiving Long GnRH Agonist Protocol in Intracytoplasmic Sperm Injection Cycles
NCT03291860 is registered in ClinicalTrials.gov with Ain Shams Maternity Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antimullerian Hormone as an Indicator fo Ovarian Response in Women Receiving Long GnRH Agonist Protocol in Intracytoplasmic Sperm Injection Cycles
- Lead sponsor
- Ain Shams Maternity Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 10, 2017
- Completion date
- October 10, 2018
- Enrollment
- 66 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.